KR927003525A - 술폰아닐리드 유도체 및 의약 - Google Patents

술폰아닐리드 유도체 및 의약 Download PDF

Info

Publication number
KR927003525A
KR927003525A KR1019920701774A KR920701774A KR927003525A KR 927003525 A KR927003525 A KR 927003525A KR 1019920701774 A KR1019920701774 A KR 1019920701774A KR 920701774 A KR920701774 A KR 920701774A KR 927003525 A KR927003525 A KR 927003525A
Authority
KR
South Korea
Prior art keywords
compound represented
following formula
compound
medicines
sulfonanilide derivatives
Prior art date
Application number
KR1019920701774A
Other languages
English (en)
Other versions
KR0150649B1 (ko
Inventor
아키라 모리노
이와오 모리타
신이치 다다
Original Assignee
아만 히데아키
닛폰신야쿠가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아만 히데아키, 닛폰신야쿠가부시키가이샤 filed Critical 아만 히데아키
Publication of KR927003525A publication Critical patent/KR927003525A/ko
Application granted granted Critical
Publication of KR0150649B1 publication Critical patent/KR0150649B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Dental Preparations (AREA)

Abstract

내용 없음

Description

술폰아닐리드 유도체 및 의약
[도면의 간단한 설명]
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (2)

  1. 다음식[I]
    으로 표시되는 화합물, 다음식[II]
    으로 표시되는 화합물, 다음식[III]
    으로 표시되는 화합물, 다음식[IV]
    으로 표시되는 화합물, 다음식[V]
    으로 표시되는 화합물, 다음식[VI]
    으로 표시되는 화합물, 의 상기[I]-[VI]의 화합물로 구성되는 군에서 선택되는 하나의 화합물, 또는 그 광학활성체 또는 이들의 약리학적으로 허용되는 염.
  2. 청구항의 1기재의 화합물을 주성분으로 하는 요 실금 치료제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019920701774A 1990-02-07 1991-02-06 술폰아닐리드 유도체 및 의약 KR0150649B1 (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP90/27675 1990-02-07
JP2767590 1990-02-07
JP90/136360 1990-05-25
JP13636090 1990-05-25
JP90/278041 1990-10-16
JP27804190 1990-10-16
PCT/JP1991/000138 WO1991012236A1 (fr) 1990-02-07 1991-02-06 Derive de sulfonanilide et medicament

Publications (2)

Publication Number Publication Date
KR927003525A true KR927003525A (ko) 1992-12-18
KR0150649B1 KR0150649B1 (ko) 1998-10-15

Family

ID=27285908

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920701774A KR0150649B1 (ko) 1990-02-07 1991-02-06 술폰아닐리드 유도체 및 의약

Country Status (14)

Country Link
EP (1) EP0538469B1 (ko)
JP (1) JPH0819084B2 (ko)
KR (1) KR0150649B1 (ko)
CN (1) CN1043526C (ko)
AT (1) ATE128459T1 (ko)
AU (1) AU637197B2 (ko)
BR (1) BR9105995A (ko)
CA (1) CA2075482C (ko)
DE (1) DE69113466T2 (ko)
DK (1) DK0538469T3 (ko)
ES (1) ES2078507T3 (ko)
GR (1) GR3018226T3 (ko)
HU (3) HUT63827A (ko)
WO (1) WO1991012236A1 (ko)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091181B2 (en) 1994-12-12 2006-08-15 Omeros Corporation Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
DE4447389A1 (de) * 1994-12-22 1996-06-27 Schering Ag Disubstituierte p-Fluorbenzolsulfonamide
FR2737494B1 (fr) 1995-08-04 1997-08-29 Synthelabo Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
FR2768055A1 (fr) 1997-09-11 1999-03-12 Synthelabo Utilisation de derives de sulfonanilide pour obtenir un medicament destine au traitement de l'ejaculation retrograde ou de l'aspermie
WO2000010557A1 (fr) * 1998-08-25 2000-03-02 Nippon Shinyaku Co.,Ltd. Preparations solides stabilisees
US7973068B2 (en) 1998-10-20 2011-07-05 Omeros Corporation Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
US20030087962A1 (en) 1998-10-20 2003-05-08 Omeros Corporation Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
ES2239466T3 (es) * 1998-10-20 2005-09-16 Omeros Corporation Solucion de irrigacion y metodo de inhibicion del dolor y de la inflamacion.
AU3325900A (en) * 1999-04-01 2000-10-23 Asahi Kasei Kabushiki Kaisha Method for the preparation of tricyclic amino alcohol derivatives through azides
WO2001040173A1 (fr) * 1999-11-29 2001-06-07 Nippon Shinyaku Co., Ltd. Procede de separation et de purification
US6323231B1 (en) 2000-02-17 2001-11-27 Abbott Laboratories Use of α1A adrenoceptor agonists with α1B and α1D antagonism for the treatment of stress urinary incontinence
US6660772B2 (en) 2001-02-01 2003-12-09 Boehringer Ingelheim Pharma Kg Use of 2-amino-1-(4-hydroxy-2-methanesulfonamidophenyl)ethanol for treating urinary incontinence
DE10104369A1 (de) * 2001-02-01 2002-08-08 Boehringer Ingelheim Pharma Verwendung von 2-Amino-(4-hydroxy-2-methansulfonamidophenyl)ethanol zur Behandlung der Harninkontinenz
DE10352132A1 (de) * 2003-11-04 2005-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Zusammensetzung aus einem Beta-3-Adrenozeptor-Agonisten und einem Alpha Agonisten
CN102234237B (zh) * 2010-04-22 2014-03-26 赤峰艾克制药科技股份有限公司 L-苯福林盐酸盐的制备方法
CN101863847B (zh) * 2010-07-02 2012-01-11 浙江省诸暨合力化学对外贸易有限公司 一种磺酰苯胺类化合物的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3566886D1 (en) * 1984-05-04 1989-01-26 Upjohn Co N-(aminoalkylphenyl)sulfonamides their preparation and therapeutic use
GB8809314D0 (en) * 1988-04-20 1988-05-25 Wellcome Found Anti-hypertensive sulfonanilides

Also Published As

Publication number Publication date
JPH0819084B2 (ja) 1996-02-28
DK0538469T3 (da) 1996-01-15
KR0150649B1 (ko) 1998-10-15
CN1043526C (zh) 1999-06-02
EP0538469A1 (en) 1993-04-28
DE69113466T2 (de) 1996-03-14
AU637197B2 (en) 1993-05-20
EP0538469A4 (en) 1992-09-28
HU211578A9 (en) 1995-12-28
HU9202515D0 (en) 1992-10-28
ATE128459T1 (de) 1995-10-15
BR9105995A (pt) 1992-11-17
HU00207A9 (en) 1995-09-28
GR3018226T3 (en) 1996-02-29
CN1054249A (zh) 1991-09-04
HUT63827A (en) 1993-10-28
AU7213891A (en) 1991-09-03
WO1991012236A1 (fr) 1991-08-22
CA2075482C (en) 1999-08-31
ES2078507T3 (es) 1995-12-16
DE69113466D1 (de) 1995-11-02
EP0538469B1 (en) 1995-09-27

Similar Documents

Publication Publication Date Title
KR927003525A (ko) 술폰아닐리드 유도체 및 의약
KR920021555A (ko) 비사이클릭 라파 마이신
KR920700204A (ko) 트리아진유도체 및 그것을 유효성분으로 하는 제초제
KR920019342A (ko) 골질환 치료제
KR890003720A (ko) 벤조티아졸 및 그를 유효성분으로 함유하는 항류머티스제
KR950013511A (ko) 실금 치료
KR930703303A (ko) 1, 4-벤조티아제핀 유도체
TR199701654T1 (xx) 4-Fenilaminotiyazol t�revleri.
ATE38991T1 (de) In 2-stellung substituierte 1,3propyledendephosphonat-derivate, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
ES2108129T3 (es) Nuevos derivados de pirazina, su preparacion y empleo.
KR900003163A (ko) 시클로헥산 유도체
KR960006915A (ko) 췌장염의 치료 조성물
KR960007592A (ko) 신규한 피롤로카바졸
KR910004191A (ko) 신질환치료제
KR970061246A (ko) 테스토스테론을 증가시키기 위한 약학 조성물
KR920703050A (ko) 골형성 촉진제
KR970061248A (ko) 알츠하이머병 치료용 1, 1, 2-트리페닐부트-1-엔 유도체
KR970703147A (ko) 동맥경화 억제제(Arteriosclerosis Depressant)
KR880007494A (ko) 5-아릴-3h-1,2,4-트리아졸-3-온 및 진경제로서의 그들의 용도
EP1121932A4 (en) DRUGS FOR EYE DISEASES
KR900701262A (ko) 췌장염 등에 대한 치료제
KR890001540A (ko) 심부전증 치료제
KR920702685A (ko) 4,6-o- 히드록시포스포릴글루코사민 유도체
KR910018028A (ko) 15- 데히드록시-16-옥소프로스타글란딘 화합물에 의한 생화학적 치료
KR920003972A (ko) 프로스타시클린 화합물을 이용한 백내장 치료

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee